596 related articles for article (PubMed ID: 19266092)
1. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.
Bennett DE; Camacho RJ; Otelea D; Kuritzkes DR; Fleury H; Kiuchi M; Heneine W; Kantor R; Jordan MR; Schapiro JM; Vandamme AM; Sandstrom P; Boucher CA; van de Vijver D; Rhee SY; Liu TF; Pillay D; Shafer RW
PLoS One; 2009; 4(3):e4724. PubMed ID: 19266092
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
Shafer RW; Rhee SY; Pillay D; Miller V; Sandstrom P; Schapiro JM; Kuritzkes DR; Bennett D
AIDS; 2007 Jan; 21(2):215-23. PubMed ID: 17197813
[TBL] [Abstract][Full Text] [Related]
3. Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.
Rhee SY; Tzou PL; Shafer RW
Viruses; 2021 May; 13(5):. PubMed ID: 34064774
[TBL] [Abstract][Full Text] [Related]
4. Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.
Shafer RW; Rhee SY; Bennett DE
Antivir Ther; 2008; 13 Suppl 2(0 2):59-68. PubMed ID: 18575192
[TBL] [Abstract][Full Text] [Related]
5. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
[TBL] [Abstract][Full Text] [Related]
6. Evolution of HIV-1 Surveillance Drug Resistance Mutations Over 10 Years in New South Wales, Australia.
Pinto A; Carrera A; Salem H; Thapa K; Shaik A; Petoumenos K; Cunningham P; Garsia R; Dwyer D; Cooper DA; Kelleher A
AIDS Res Hum Retroviruses; 2021 Dec; 37(12):897-902. PubMed ID: 28474534
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.
Sayan M; Sargin F; Inan D; Sevgi DY; Celikbas AK; Yasar K; Kaptan F; Kutlu S; Fisgin NT; Inci A; Ceran N; Karaoglan I; Cagatay A; Celen MK; Koruk ST; Ceylan B; Yildirmak T; Akalın H; Korten V; Willke A
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):26-31. PubMed ID: 26414663
[TBL] [Abstract][Full Text] [Related]
8. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
[TBL] [Abstract][Full Text] [Related]
10. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes.
Mendoza Y; Castillo Mewa J; Martínez AA; Zaldívar Y; Sosa N; Arteaga G; Armién B; Bautista CT; García-Morales C; Tapia-Trejo D; Ávila-Ríos S; Reyes-Terán G; Bello G; Pascale JM
PLoS One; 2016; 11(4):e0154317. PubMed ID: 27119150
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.
Sadeghi L; Lolaie M; Tabatabai RA; Bayanolhagh S; Taj L; Ahmadi NE; Abedinzadeh N; Vakili F; Ahmadi G; Mohraz M
Infect Disord Drug Targets; 2018; 18(3):241-248. PubMed ID: 29663899
[TBL] [Abstract][Full Text] [Related]
13. Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure.
Gange SJ; Schneider MF; Grant RM; Liegler T; French A; Young M; Anastos K; Wilson TE; Ponath C; Greenblatt R
J Acquir Immune Defic Syndr; 2006 Jan; 41(1):68-74. PubMed ID: 16340476
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
[TBL] [Abstract][Full Text] [Related]
15. Genotypic testing for human immunodeficiency virus type 1 drug resistance.
Shafer RW
Clin Microbiol Rev; 2002 Apr; 15(2):247-77. PubMed ID: 11932232
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa.
van Zyl GU; Cotton MF; Claassen M; Abrahams C; Preiser W
Pediatr Infect Dis J; 2010 Apr; 29(4):370-1. PubMed ID: 19935449
[TBL] [Abstract][Full Text] [Related]
17. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
[TBL] [Abstract][Full Text] [Related]
18. Presence of drug resistance mutations among drug-naive patients in Morocco.
Annaz HE; Recordon-Pinson P; Baba N; Sedrati O; Mrani S; Fleury H
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):917-20. PubMed ID: 21087198
[TBL] [Abstract][Full Text] [Related]
19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
20. Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.
Santoro MM; Svicher V; Gori C; Zaccarelli M; Tozzi V; Forbici F; D'Arrigo R; Trotta MP; Bellocchi MC; Visco-Comandini U; Cenci A; Bertoli A; Narciso P; Antinori A; Perno CF; Ceccherini-Silberstein F
New Microbiol; 2006 Apr; 29(2):89-100. PubMed ID: 16841549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
